Meet ApplyKite Twin, the application assistant that learns with you
Meet your Twin, it learns with you
Your Twin learns with you
Launch week codes:30% off annual Pro20% off monthly Pro
Ends in00h00m00s
Ends in00h00m00s
Maria Aparecida Nagai
Has grant
Associate Professor
Research Interests
Explore related searches
Recent Grants
Grant: Close
Functional role of PHLDA1, RET, BCAR3 and the isoform a of the progesterone receptor (PRA) in breast cancer: clinical implications
Open Date: 2015-10-01
Close Date: 2017-09-30
Grant: Close
Evaluation of the functional role of intracellular and extracellular expression of PAR-4 (prostate apoptosis response-4) in the tumorigenic process of the breast: implications for chemosensitivity and potential antitumor
Open Date: 2013-08-01
Close Date: 2015-08-31
Grant: Close
Study of the functional role of PAR-4 and SPARC in breast cancer cell survival and chemosensitivity
Open Date: 2011-04-01
Close Date: 2013-03-31
Grant: Close
Functional characterization of genes potentially regulated by estrogen receptor and/or ERBB2 oncogene: implications in the diagnosis, prognosis and treatment of breast cancer
Open Date: 2006-11-01
Close Date: 2009-10-31
Grant: Close
Validation and characterization of differentially expressed genes in breast cancer: interaction between estrogen signaling pathways and growth factors
Open Date: 2004-04-01
Close Date: 2006-03-31
Articles (12)
Year:
2026
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Collaborators (6)
Diego Hernan Giunta
Karolinska Institutet
Roger Chammas
Professor Titular
University of Sao Paulo
Ricardo Alejandro Verdugo Salgado
Associate Professor
Universidad de Chile
Edwin Roger Parra
Associate Professor
The University of Texas MD Anderson Cancer Center
Vera Luiza Capelozzi
Professor Assistente Doutor em RDIDP (MS-5)
University of Sao Paulo
John A. Hawley
Institute Director
Australian Catholic University
Make your next move.
Prepare your application
Review drafts before you send them.